Assessment of the Prosthetic System Impact on Mental Workload in Above-knee Lower Limb Amputees.
Launched by PROTEOR GROUP · Oct 8, 2024
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different types of prosthetic systems affect the mental workload of people who have had an above-knee amputation. Essentially, it aims to understand how using new prosthetic technology influences the mental effort required for daily activities. Researchers want to see if there's a difference in this mental workload when using various prosthetic devices, both in controlled lab settings and in real-life situations.
To participate, individuals need to be aged between 18 and 84, have an above-knee amputation, and currently use a prosthetic knee and foot. They should also be able to set personal goals for their rehabilitation and have a smartphone. Participants can expect to share their experiences and help researchers gather important information that could improve future prosthetic designs. It's important to note that those who are pregnant, weigh more than 125 kg, or have certain other medical conditions may not be eligible for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • above-knee lower limb amputation
- • using an above-knee prosthesis with prosthetic knee and foot
- • eligible to use Synsys
- • able to design therapeutic objectives for the GAS
- • having a smartphone
- Exclusion Criteria:
- • protected person
- • pregnant or breast-feeding lady
- • knee-to-ground height lower than 43cm
- • weighting more than 125kg
- • using their prosthesis for less than 2 weeks
- • not covered by health insurance
- • aged less than 18 or more than 84 years old
- • bilateral amputee or hip disarticulated
About Proteor Group
Proteor Group is a leading clinical trial sponsor dedicated to advancing healthcare through innovative research and development. With a focus on biopharmaceuticals and medical devices, Proteor Group specializes in designing and executing clinical trials that adhere to the highest regulatory standards. Their experienced team collaborates with healthcare professionals, regulatory agencies, and industry partners to ensure robust trial methodologies and optimal patient safety. Committed to transparency and ethical practices, Proteor Group strives to deliver impactful solutions that enhance patient outcomes and contribute to the evolution of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Multiple Locations, , France
Patients applied
Trial Officials
Laurine Calistri, MS
Study Director
Proteor Group
Isabelle Loiret, DR
Principal Investigator
UGECM Nord-Est, IRR, Centre Louis Pierquin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported